Average Co-Inventor Count = 5.79
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie B.v. (9 from 13 patents)
2. Abbvie Inc. (6 from 822 patents)
3. Solvay Pharmaceuticals, B.v. (5 from 67 patents)
4. Abbvie Bahamas Limited (2 from 6 patents)
5. Abbvie Deutschland Gmbh and Co Kg (1 from 167 patents)
6. Abbivie Inc. (1 from 1 patent)
17 patents:
1. 11427598 - Spiro-cyclic amine derivatives as S1P modulators
2. RE48301 - Fused heterocyclic derivatives as S1P modulators
3. 10807991 - Spiro-cyclic amine derivatives as S1P modulators
4. 10179791 - Spiro-cyclic amine derivatives as S1P modulators
5. 9951084 - Spiro-cyclic amine derivatives as S1P modulators
6. 9670220 - Fused heterocyclic derivatives as S1P modulators
7. 9273017 - (Thio)morpholine derivatives as S1P modulators
8. 9096612 - Fused heterocyclic derivatives as S1P modulators
9. 9045441 - (Thio)morpholine derivatives as S1P modulators
10. 8796262 - Fused heterocyclic derivatives as S1P modulators
11. 8735388 - Heterocyclic compounds with affinity to muscarinic receptors
12. 8586606 - Heterocyclic compounds with affinity to muscarinic receptors
13. 8252930 - Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
14. 8084473 - Heterocyclic compounds with affinity to muscarinic receptors
15. 7964728 - Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition